Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups

The Food and Drug Administration is making a significant shift in its approach to COVID-19 vaccines, halting universal access for seasonal boosters and instead targeting individuals over 65 and those with severe health conditions. This decision, outlined in a New England Journal of Medicine commentary by Trump administration officials, appears to be made without input from key advisory committees typically involved in vaccine approvals, raising concerns about oversight and how it aligns with CDC guidelines.